Visiopharm Acquires Digital Pathology Consultants

| December 6, 2012

Cool news from Denmark today. Congratulations to Michael, Amanda and their companies. As longtime friends, collaborators and partners in the digital pathology space, good news for the industry. Acquistion brings a marketing presence to North America and beyond for Visiopharm.

Visiopharmlogo2012

Visiopharm, a leading provider of quantitative
digital pathology solutions, has entered into a final agreement to acquire Digital
Pathology Consultants, LLC based in Westminster, Colorado. The transaction is
expected to be completed by the end of December. Amanda Lowe, founder of
Digital Pathology Consultants, will join the management team as the Director of
Marketing for Visiopharm in the Americas. Ms. Lowe has over 8 years experience
in all aspects of Digital Pathology.

Michael Grunkin PhD, CEO of Visiopharm
stated “Amanda Lowe is highly respected in this field and has been at the core
of the Digital Pathology industry since its beginning. Her experience and
holistic view of Digital Pathology will become an invaluable asset to our
business partners and to our rapidly growing base of digital pathology adopters
in the Americas.”

Ms. Lowe stated “I am extremely excited
to join the very talented team at Visiopharm. Visiopharm’s solutions for
quantitative digital pathology provide customers with cutting edge innovation
that delivers superior results. I look forward to driving Visiopharm’s growth
throughout the Americas.”

About Visiopharm

Over the past 10 years, Visiopharm
image analysis and stereology software has become the preferred Quantitative
Digital Pathology solution for leading biopharmaceutical companies, clinical
researchers, and academic researchers all over the world. Visiopharm has more
than 300 deployed systems worldwide and a large network of distribution and
support partners, and is featured in over 400 scientific publications.

About Digital Pathology Consultants

Digital Pathology Consultants, a
consultancy firm founded in 2009, was formed to advise current and potential
digital pathology users within the healthcare, research, and biopharmaceutical
markets on how to be productive and financially successful with digital
pathology solutions. Digital Pathology Consultants also provided a large range
of advisory services to the commercial digital pathology market including
business development, strategic planning, and market research.

 


Category: Digital Pathology News, Pathology News

Comments are closed.